Acrivon Therapeutics Inc. (NASDAQ: ACRV) announced it will provide clinical data updates on its drug candidates ACR-368 and ACR-2316 in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE